Why may prenatal testing be offered to families at high risk for a metabolic disease?

Prenatal testing is offered to families at high risk for a metabolic disease primarily to facilitate early diagnosis and intervention. Because many metabolic disorders are hereditary, families who have previously had a child with such a condition or belong to a specific ethnic group—such as the Ashkenazi Jewish population in the case of Tay-Sachs disease—are often identified as high-risk.1

The primary goal of this testing is to improve the infant's prognosis. For some metabolic disorders, early detection allows for the initiation of appropriate therapy shortly after birth, which can significantly improve health outcomes. In cases where a condition responds well to early treatment, this proactive approach is vital. However, it is important to acknowledge that for other metabolic disorders, no effective therapy currently exists, and the condition may cause severe health problems despite early diagnosis.1

Ultimately, providing this information allows families to make informed decisions regarding their pregnancy, supported by genetic counseling to ensure they receive accurate information and feel supported in their choices.2